Involvement of α5 integrin in survivin-mediated osteosarcoma metastasis

Xiao-Zhou Liu1, Cheng-Jun Li2, Su-Jia Wu2

  • 1Southern Medical University, Guangzhou 510515, China; Department of Orthopedics, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China.

Abstract

Insights

Survivin knockdown inhibits osteosarcoma (bone cancer) cell invasion and migration by reducing α5 integrin. This suggests survivin-targeting therapies may effectively treat osteosarcoma metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Osteosarcoma is a primary bone cancer with a high risk of metastasis.
  • Survivin is a protein implicated in cancer cell proliferation, apoptosis, and angiogenesis.
  • The role of survivin in osteosarcoma metastasis requires further elucidation.

Purpose of the Study:

  • To investigate the role of survivin in osteosarcoma metastasis.
  • To determine the relationship between survivin and α5 integrin expression in osteosarcoma cells.
  • To evaluate the therapeutic potential of targeting survivin in osteosarcoma.

Main Methods:

  • Small interfering RNA (siRNA) was used to knockdown survivin and α5 integrin expression in MG63 osteosarcoma cells.
  • Western blotting, immunostaining, flow cytometry, and fluorescence microscopy assessed protein expression.
  • In vitro assays (Transwell, wound healing) and in vivo studies in nude mice evaluated cell invasion, migration, and tumor growth.

Main Results:

  • Survivin knockdown significantly inhibited osteosarcoma cell invasion and migration in vitro.
  • Survivin knockdown reduced the expression of α5 integrin on the cell surface.
  • Targeting α5 integrin with an antibody also decreased cell invasion and migration.
  • In vivo, survivin knockdown slowed tumor growth in nude mice.

Conclusions:

  • Survivin plays a crucial role in promoting osteosarcoma cell invasion and migration, partly through the regulation of α5 integrin.
  • Targeting survivin represents a promising therapeutic strategy for controlling osteosarcoma metastasis.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.4K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Metastasis02:30

Metastasis

3.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K